Genes Highlight Who'll Benefit From Multiple Myeloma Treatment …
Dec 4, 2024 · Multiple myeloma is a cancer of blood plasma cells, according to the American Cancer Society. About 35,780 new cases of multiple myeloma are expected to be diagnosed …
Sarclisa Approved in the US as the First Anti-CD38 Therapy in ...
“Multiple myeloma is most frequently diagnosed in patients 65 years and older, yet the options for treatment in this population are limited due to a combination of age, frailty, and co-morbidities. …
FDA Approves Darzalex Faspro for Treating Multiple Myeloma
Aug 8, 2024 · "Multiple myeloma has a highly varied clinical course among patients and in each individual patient, and there is a continued need for innovation and therapies that employ …
Multiple Myeloma News & Updates - Drugs.com
TUESDAY, Oct. 8, 2024 – Ciltacabtagene autoleucel (cilta-cel) CAR T-cell therapy for relapsed/refractory multiple myeloma (RRMM) results in a deep and durable response, …
ASH: Daratumumab Beneficial for Patients With Multiple Myeloma
WEDNESDAY, Dec. 13, 2023 -- For transplantation-eligible patients with newly diagnosed multiple myeloma, the addition of subcutaneous daratumumab combined with bortezomib, …
Cilta-Cel Treatment Safe, Effective for Relapsed/Refractory …
TUESDAY, Oct. 8, 2024 -- Ciltacabtagene autoleucel (cilta-cel) CAR T-cell therapy for relapsed/refractory multiple myeloma (RRMM) results in a deep and durable response, …
Multiple Myeloma - What You Need to Know - Drugs.com
Dec 2, 2024 · Multiple Myeloma. Medically reviewed by Drugs.com. Last updated on Dec 2, 2024. Care notes; Ambulatory; Discharge; Inpatient; Español; Overview; Symptoms; Diagnosis; …
How effective is Velcade for multiple myeloma? - Drugs.com
Oct 25, 2024 · Relapsed multiple myeloma has previously responded to treatment but has come back. Dexamethasone is a corticosteroid treatment that is stronger and longer-acting than …
Triplet Therapy Including Belamaf Prolongs Survival in Multiple …
FRIDAY, Feb. 9, 2024 -- For patients with relapsed or refractory multiple myeloma (RRMM), triplet therapy of belantamab mafodotin (belamaf) plus bortezomib and dexamethasone (BVd) …
Can Venclexta be used for Multiple Myeloma? - Drugs.com
Aug 8, 2024 · Although Venclexta is not FDA approved for use in Multiple Myeloma (MM), some research indicates that it may be promising for some MM patients who have failed at least one …